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ABSTRACT 
The aim of current study was to explore crude extracts and various fractions of title plant for 
reversal of multi-drug resistance and anti-proliferative activities in mouse lymphoma cells. The 
extracts and various fractions were screened for the reversal of MDR of mouse lymphoma cell line 
transfected by ABCB1 gene and then the intracellular accumulation of rhodamine 123 (an 
analogue of epirubicine; a fluorescent substrate) was measured by flow cytometry. The transporter 
modulating potential of ABCB1 gene was evaluated by the fluorescence activity ratio (FAR) value. 
In the flow cytometry, the values of FSC (forward scatter count) and SSC (side scatter count) were 
increased indicating that the test samples have membrane effect due to which the granulation of 
cytoplasm was increased. All the test samples were screened at two different concentrations (2 and 
20µg/ml) on MDR mouse lymphoma cells. The result showed that at low concentration (2µg/ml) 
only the CHCl3 fraction (FAR=21.79) was more effective MDR modulator while the remaining 
test samples were less active. At high concentration (20µg/ml), the CHCl3 fraction (FAR=68.91) 
was more effective followed by the EtOAc (FAR=23.42) and n-hexane (FAR=16.25) fractions. 
Rest of the test samples showed low effect in a short time experiment. 
The results showed that the EtOAc fraction has good anti-proliferative effect with IC50 value of 
12.33µg/ml followed by the CHCl3 (IC50 = 17.24µg/ml) and n-hexane (IC50 = 17.32µg/ml) 
fractions on the mouse T-cell lymphoma. The remaining test samples showed low effect on the 
cells. 
Keywords: Anticancer, Picea smithiana, Multidrug resistance, Anti-proliferative, mouse 
lymphoma cells. 
  
INTRODUCTION 
Humans has a very deep relationship with the nature due to their basic needs of food, shelter and 
medicines. For this purpose they are curious about different plants and their role in the treatment 
of different diseases [1]. Knowledge of modern medicine is believed to be derived from traditional 
medicines [2]. Herbal products and their derivatives contribute about 50% of the clinical medicines 
[3, 4]. A large number of pharmaceuticals is derived from plants because they not only produce 
different bioactive primary and secondary metabolites but can also be modified effectively [5]. A 
wide range of diseases including stomach, headache and different types of wounds and cuts can 
be cured by medicinal plants [6]. The use of herbal medicine is also encouraged by World Health 
Organization (WHO) especially in backward countries. In South Asia, about 8000 pharmaceutical 
plants are used for various diseases among which 19% are found in Pakistan [7]. Based on the 
knowledge of folk medicines, about 119 different type of drugs of plant origin were introduced to 
the market [8]. WHO survey shows that more than 80% population of the developing countries 
depend on herbal medicines [8] whereas about 25% population of United States (US) is also 
dependent on plant derived products [9]. The survey also showed that more than 20,000 herbal 
plants are used in traditional drug system which is now increased to 70,000 all over the world [10]. 
Similarly, about 90 products of plant origin which are used in conventional medicines were 
discovered by utilizing the knowledge of local people [11]. A single herbal medicine can be used 
to cure different diseases as confirmed from clinical results. The current study also deals with one 
of such promising plant. 
Picea smithiana (Wall) Boiss is the member of family Pinaceae which is commonly known as 
Himalayan spruce. This tree grows at the altitude of 2,000-3,000 meters in Afghanistan, India, 
Nepal and Pakistan [12]. In Pakistan, it can be found in Kurram, Chitral, Swat, Dir, Gilgit, Kaghan 
and Kashmir [12]. This plant is traditionally used for the treatment of human pathologies like skin 
diseases, renal disorders and ophthalmic ailments [13]. Thus, the current study aims to validate the 
medicinal potential of P. smithiana by evaluating its in vitro anticancer activities such as reversal 
of multidrug resistance (MDR) and anti-proliferative potential on mouse lymphoma cells. 
EXPERIMENTAL 
Collection and Identification of the Plant material 
Picea smithiana (wall) Boiss was collected from Swat, Khyber Pakhtunkhwa (KP), Pakistan in 
July, 2015 and was identified and confirmed by Dr. Lal Badshah, Department of Botany, 
University of Peshawar, Pakistan. 
Processing and Extraction 
The plant was washed, chopped, shade dried and finally pulverized. The pulverized plant material 
(15kg) was soaked in commercial grade methanol for 15 days and then filtered with muslin cloth. 
The filtrate was concentrated at reduced pressure with the help of rotary evaporator at 40oC, 
resulting in a dark green-colored crude methanolic extract (crude MeOH extract) (900 g). 
Fractionation 
Suspension of crude MeOH extract in distilled water (500ml) was prepared and partitioned in 
separating funnel with solvents of different polarity starting from less polar to more polar i.e. n-
hexane, chloroform (CHCl3), ethyl acetate (EtOAc) and n-butanol (BuOH) which yielded 260g of 
n-hexane, 130g of CHCl3, 170g of EtOAc, 110g of BuOH and 125g of aqueous fractions. 
 
Other chemicals used in the study as reagents were: verapamil (EGIS Pharmaceutical Company, 
Budapest, Hungary), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; 
Sigma, St Louis, MO, USA), sodium dodecyl sulphate (SDS; Sigma) and dimethyl sulfoxide 
(DMSO; Sigma). All solutions were prepared on the day of assay. 
 Cell lines 
The L5178Y mouse T-cell lymphoma cells (PAR) (ECACC Cat. No. 87111908, obtained from 
FDA, Silver Spring, MD, USA) were transfected with pHa MDR1/A retrovirus, as previously 
described by Cornwell et al. The ABCB1-expressing cell line L5178Y (MDR) was selected by 
culturing the infected cells with colchicine. The L5178Y human ABCB1-transfected subline was 
cultured in McCoy’s 5A medium (Sigma-Aldrich, St Louis, MO, USA) supplemented with 10% 
heat-inactivated horse serum (Sigma-Aldrich, St Louis, MO, USA), 200 mM L glutamine (Sigma-
Aldrich, St Louis, MO, USA) and a penicillin-streptomycin (Sigma-Aldrich, St Louis, MO, USA) 
mixture in concentrations of 100 U/L and 10 mg/L, respectively. 
NIH/3T3 mouse embryonic fibroblast cell line (ATCC CRL-1658) were purchased from LGC 
Promochem, Teddington, UK. The cell line was cultrued in Dulbecco’s Modified Eagle’s Medium 
(DMEM, containing 4.5g/L glucose) supplemented with 10% heat-inactivated fetal bovine serum. 
The cell lines were incubated at 37˚C, in a 5% CO2, 95% air atmosphere. 
 
Assay for antiproliferative effect 
The assays for antiproliferative effects were performed following the procedure described in [18, 
19]. The effects of increasing concentrations of the tested extracts on cell growth were tested in 
96-well flat-bottomed microtiter plates. The extracts were diluted in a volume of 100 μl medium. 
The parental and multidrug resistant mouse T-lymphoma cells were cultured using McCoy’s 5A 
medium supplemented with 10% heat-inactivated horse serum. The density of the cells was 
adjusted to 1x104 cells per well (in 100 μL of medium per well) and then added to the 96-well flat-
bottomed microtiter plates containing the dilutions of the tested compounds. The culture plates 
were incubated at 37°C, in a 5% CO2, 95% air atmosphere. 
The adherent mouse embryonic fibroblast cells were cultured in 96-well flat-bottomed microtiter 
plates, using DMEM supplemented with 10% heat-inactivated fetal bovine serum. The culture 
plates were incubated at 37°C, in a 5% CO2, 95% air atmosphere. In a separate plate, the respective 
dilutions of the different extracts were prepared. The density of the cells was adjusted to 1x104 
cells per well, the cells were seeded for 4 h at 37°C, 5% CO2, then the medium was removed from 
the plates containing the cells, and the dilutions previously made were added to the cells. 
The culture plates were incubated at 37˚C for 72 h; at the end of the incubation period, 20 μL of 
MTT (thiazolyl blue tetrazolium bromide, Sigma) solution (from a stock solution of 5 mg/mL) 
were added to each well. After incubation at 37˚C for 4 h, 100 μL of sodium dodecyl sulfate (SDS) 
(Sigma) solution (10% in 0.01 M HCI) were added to each well and the plates were further 
incubated at 37˚C overnight. Cell growth was determined by measuring the optical density (OD) 
at 540/630 nm with Multiscan EX ELISA reader (Thermo Labsystems, Cheshire, WA, USA). 
Inhibition of the cell growth was determined according to the formula below: 
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During this assay, the selectivity indices (SI) of the tested extracts were also determined, 
comparing the IC50 values of the PAR and MDR mouse lymphoma cells, and the IC50 values of 
the lymphoma cells and the values of the non-cancerous embryonic fibroblast cells. The 
compounds should be categorized, based on the selectivity indices as low (SI<1), moderate 
(3<SI<6) and highly selective (SI>6) (Acton et al., Gajdács et al.) 
 
 
Rhodamine 123 (R123) accumulation assay  
The inhibition of the cancer MDR efflux pump ABCB1 by the tested extracts was evaluated using 
flow cytometry, measuring the retention of rhodamine 123 by ABCB1 (P-glycoprotein) in MDR 
mouse T-lymphoma cells, as the L5178Y human ABCB1-gene transfected mouse T-lymphoma 
cell line (MDR) overexpress P-glycoprotein. This method is a fluorescence-based detection system 
which uses verapamil as reference inhibitor. Briefly, the cell number of L5178Y MDR and 
L5178Y PAR cell lines were adjusted to 2×106 cells/ml, re-suspended in serum-free McCoy’s 5A 
medium and distributed in 0.5 ml aliquots into Eppendorf centrifuge tubes. The tested compounds 
were added at different concentrations and the samples will be incubated for 10 minutes at room 
temperature. Verapamil (Sigma, St. Louis, MO. USA) was applied as positive control. Next, 10 µl 
(5.2 µM final concentration) of the fluorochrome and ABCB1 substrate rhodamine 123 (Sigma, 
St. Louis, MO, USA) were added to the samples and the cells were incubated for a further 20 
minutes at 37°C, washed twice and re-suspended in 0.5 ml PBS for analysis. The fluorescence of 
the cell population was measured with a Partec CyFlow® flow cytometer (Partec, Münster, 
Germany). The percentage of mean fluorescence intensity was calculated for the treated MDR 
cells as compared with the untreated cells. A fluorescence activity ratio (FAR) was calculated 
based on the following equation which relates the measured fluorescence values: 
controltreated
controltreated
parentalparental
MDRMDR
FAR =  
Quotient = 100 x (FARextract/FARverapamil) 
 
The results obtained from a representative flow cytometry experiment in which 10,000 individual 
cells of the population will be evaluated for amount of rhodamine 123 retained with the aid of the 
Partec CyFlow® flow cytometer, are first presented by the histograms and this data converted to 
FAR units that define fluorescence intensity, standard deviation, peak channel in the total- and in 
the gated- populations. Parameters calculated are: Forward Scatter (FSC, Forward scatter count of 
cells in the samples or cell size ratio); Side Scatter (SSC, Side scatter count of cells in the samples); 
FL-1 (Mean fluorescence intensity of the cells) and FAR or fluorescence activity ratio, whose 
values were calculated by using the equation above.  
  
RESULTS 
Assay for reversal of multidrug resistance in mouse lymphoma cells 
One of the main hurdle in chemotherapy of malignant tumors is the development of MDR. There 
are many mechanisms through which MDR is developed [20]. Most of the resistance offered to 
anticancer drugs is due to the expression of two members of membrane transporter ATP-binding 
cassette (ABC) superfamily; P-glycoprotein (P-gp) which is 170 kDa and multidrug resistance 
protein (MRP) which is 190 kDA [21]. Food such as fruit and vegetables are proved to have anti-
cancer effect [22]. Food derived from plants contains many nutrients like carotenoids, fiber, folate, 
vitamin C, minerals, phenolics such as flavonoids which are proved to have cancer-preventive 
effects [23].  
The test samples were screened for the reversal of MDR of mouse lymphoma cell line transfected 
by ABCB1 gene and then the intracellular accumulation of rhodamine 123 (an analogue of 
epirubicine; a fluorescent substrate) was measured by flow cytometry. The transporter modulating 
potential of ABCB1 gene was evaluated by the fluorescence activity ratio (FAR) value as shown 
in Table 1. In the flow cytometry, the values of FSC (forward scatter count) and SSC (side scatter 
count) were increased indicating that the test samples have membrane effect due to which the 
granulation of cytoplasm was increased. All the test samples were screened at two different 
concentrations (2 and 20µg/ml) on MDR mouse lymphoma cells. The result showed that at low 
concentration (2µg/ml) only the CHCl3 fraction (FAR=21.79) was more effective MDR modulator 
while the remaining test samples were less active. At high concentration (20µg/ml), the CHCl3 
fraction (FAR=68.91) was more effective followed by the EtOAc (FAR=23.42) and n-hexane 
(FAR=16.25) fractions. Rest of the test samples showed low effect in a short time experiment. 
 
  
Table 1. Effect of crude MeOH extract and various fractions of P. smithiana on the reversal of MDR mouse lymphoma cells 
  
 
  
 
 
 
1  - 1799 783 124 - 115 
2  - 1803 747 115 - 104 
3  - 2038 993 1.49 - 1.04 
      
   1.1015 - - 
4  20 2029 994 3.64 3.30 1.24 
5  
2 2082 995 0.874 0.79 0.583 
20 2046 1142 5.43 4.93 1.07 
6  
2 2059 1017 1.65 1.49 0.835 
20 1886 1256 17.9 16.25 1.38 
7 
 
2 1977 986 24 21.79 25.5 
20 1868 1372 75.9 68.91 89.8 
8  
2 2013 1050 3.11 2.82 1.24 
20 1861 1435 25.8 23.42 26.4 
9  
2 1997 1041 0.971 0.88 0.75 
20 2008 1194 5.5 4.99 2.05 
10  
2 1968 1047 1.09 0.99 0.866 
20 1913 1255 1.17 1.06 0.965 
11  2% 1912 922 0.673 0.61 0.542 
12  - 1888 997 0.713  - 0.604 
 Table 2.: Effect of crude MeOH extract on rhodamine 123 accumulation 
by multidrug resistant (MDR) mouse T-lymphoma cells 
Sample Concentration (µg/mL) FAR FAR quotient (%) 
Verapamil 20 3.3 
100.00 
Crude 
MeOH 
extract 
2 0.79 
23.94 
20 
4.93 
149.39 
n-hexane 
2 1.49 
45.15 
20 16.25 
492.42 
CHCl3 
2 21.79 
660.30 
20 68.91 
2088.18 
EtOAc 
2 2.82 
85.45 
20 23.42 
709.70 
BuOH 
2 0.88 
26.67 
20 4.99 
151.21 
Aqueous 
2 0.99 
30.00 
20 1.06 
32.12 
FAR: fluorescence activity ratio 
 
  
 Anti-proliferative assay 
The abnormal and uncontrolled proliferation of cells in the body is referred to as cancer. It is one 
of the leading source of death in developing as well as developed countries [24, 25]. Many 
conventional drugs for prevention of cancer have been developed which have properties of 
cytotoxicity, anti-inflammation, anti-proliferation, autophagy and induction of apoptosis [26] but 
these drugs have side effects such as toxicity, drug resistance and unaffordability [27]. Therefore, 
development of alternate therapy is much needed and in this regard development of herbal 
medicine has gained much interest because herbal medicines are locally available, easily 
accessible, affordable and have less drug toxicity [28]. 
The test samples were screened for anti-proliferative effect on mouse T-cell lymphoma (L5178Y) 
transfected by ABCB1 gene of human, which exclusively overexpress a membrane localized 
transporter called the P-glycoprotein. The effect on the cell growth was determined by using the 
MTT method. The results (Table 2) showed that the EtOAc fraction has good anti-proliferative 
effect with IC50 value of 12.33µg/ml followed by the CHCl3 (IC50 = 17.24µg/ml) and n-hexane 
(IC50 = 17.32µg/ml) fractions on the mouse T-cell lymphoma. The remaining test samples showed 
low effect on the cells. 
  
 Table 3. Anti-proliferative effect of crude MeOH extract and various fractions of P. smithiana on 
NIH/3T3 mouse embryonal fibroblast and PAR/MDR mouse T-lymphoma cells 
 
Table X.: Antiproliferative effects of the tested extracts on parental and multidrug resistant mouse 
T-lymphoma cells 
Sample 
(A) NIH/3T3 
mouse embryonic 
fibroblast cells 
(B)  
Parental (PAR) mouse T-
lymphoma cellss 
(C)  
Multidrug 
resistant 
(MDR) mouse 
T-lymphoma 
cells 
 
IC50 
(µg/mL) 
SD ±- 
IC50  
(µg/mL) 
SD 
±- 
IC50  
(µg/mL) 
SD ± 
SI 
(B/C) 
SI 
(A/B) 
SI 
(A/C) 
Crude 
MeOH 
extract 
>100  32.61 4.83 45.39 6.36 0.72 > 3.06 > 2.20 
n-hexane >100  12.87 2.81 17.32 0.76 0.74 > 7.77 > 5.78 
CHCl3 >100  28.54 3.85 17.24 0.65 1.66 > 3.50 > 5.80 
EtOAc >100  67.98 2.85 12.33 1.89 5.52 > 1.47 > 8.11 
BuOH >100  67.57 4.49 69.55 0.21 0.97 > 1.48 > 1.43 
Aqueous >100  94.82 0.81 >100 - < 0.94 > 1.05 1.00 
SD, standard deviation; SI, selectivity index; ND, not determined 
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